Stock screenerAll disclosures →
EDGAR →
DYN
Conviction 89HealthcareScan · Thu, Jun 25, 2026DYN$20.63+1.48%
ResistanceSupportVol 14Insider buyInsider sell4
4
4
4
4
4
4
5
9
3
Vol MA14 2.32M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price20.63
Change+1.48%
Gap+0.15%
Rel volume2.39×
Avg volume2.08M
Avg $ vol39.57M
SMA 2018.68
SMA 5018.39
SMA 20017.81
Price vs 50+12.17%
Price vs 200+15.85%
MA stackbullish
50/200 cross—
Supertrendup · 17.26
RSI (14)62
MACD hist0.30
MACD crossbull · 8d
Stoch %K / %D82 / 77
ADX (14)21
+DI / −DI30 / 13
RSI divergence—
MACD divergence—
ATR %+5.55%
ADR %5.98%
52w high24.29
52w low8.18
From 52w high-15.07%
Above 52w low+152.20%
New 52w highNo
SqueezeOff
Bollinger width25.03%
%B0.92
Donchian pos81.73%
Donchian high21.54
Donchian low16.56
AVWAP (52w high)18.84
vs AVWAP high+9.50%
AVWAP (52w low)16.56
vs AVWAP low+24.60%
OBV trendUp
Chaikin MF (20)-0.09
Today vs 20d2.39×
Avg vol (14d)2.32M
Avg vol (20d)2.08M
Avg $ vol (20d)39.57M
Market cap2.95B
RS 3m (vs SPY)+1.64%
RS 6m (vs SPY)-5.32%
RS line new highNo
Trend template8/8
Technical rank71.3
1 week+7.45%
1 month+13.66%
3 months+8.69%
6 months-0.72%
1 year+94.07%
YTD+11.51%
P/E-6.60
P/B3.41
P/S—
P/FCF-7.27
EPS-3.47
Div yield—
ROE-51.58%
ROA-41.32%
Debt/Eq0.01
Current19.92
EV/EBITDA-4.73
Gross margin—
Net margin—
Rev growth—
EPS growth-40.58%
Price target39.00
Target upside89.05%
Analyst ratingBuy
Institutional121.28%
Ent. value2.2B
Revenue—
Net income-120.85M
Gross profit—
Free cash flow-405.13M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out165.31M
Employees258
ListedThu, Sep 17, 2020
Free float148.8M
Float %90.1%
Short interest22.28M
Days to cover14.6d
Short volume62.4%
Squeeze score85 / 100
Next earningsMon, Jul 27, 2026 (32d)
EPS forecast−$0.74 · 8 est
Last EPS vs est−$0.73 vs −$0.74
Last surprise+1.4% beat
Setup gradeA+
Conviction89 / 100
Pattern quality—
Tech rank71.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.58
Support16.22
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DYN
No recent disclosed trades by Congress in DYN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DYN · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kersten Dirk Director · Common Stock · 2026-06-18 | Sell | 46.9K | $941K | 2026-06-18 | 2026-06-22 |
Kersten Dirk Director · Common Stock · 2026-06-17 | Sell | 37.45K | $754K | 2026-06-17 | 2026-06-22 |
Posner Brian S Director · Common Stock · 2026-06-08 | Buy | 2K | $34K | 2026-06-08 | 2026-06-09 |
Stehman-Breen Catherine Director · Stock option (right to buy) · 2026-06-05 | Grant | 35.15K | $0 | 2026-06-05 | 2026-06-09 |
Lubner David Charles Director · Stock option (right to buy) · 2026-06-05 | Grant | 35.15K | $0 | 2026-06-05 | 2026-06-09 |
Incerti Carlo Director · Stock option (right to buy) · 2026-06-05 | Grant | 35.15K | $0 | 2026-06-05 | 2026-06-09 |
Rhodes Jason P Director · Stock option (right to buy) · 2026-06-05 | Grant | 35.15K | $0 | 2026-06-05 | 2026-06-09 |
Posner Brian S Director · Stock option (right to buy) · 2026-06-05 | Grant | 35.15K | $0 | 2026-06-05 | 2026-06-09 |
HURWITZ EDWARD Director · Stock option (right to buy) · 2026-06-05 | Grant | 35.15K | $0 | 2026-06-05 | 2026-06-09 |
Kersten Dirk Director · Stock option (right to buy) · 2026-06-05 | Grant | 35.15K | $0 | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in DYN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.